• Monte Rosa Therapeutics granted four newly hired non-executive employees equity awards under its 2026 Inducement Plan, effective November 2, 2026.
• Non-qualified stock options cover 33,775 shares, vesting 25% on the first grant anniversary, followed by 36 equal monthly installments.
• Restricted stock units cover 7,400 shares, vesting 25% on each of the first four grant anniversaries.
• All awards require continued service through each applicable vesting date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Monte Rosa Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611031601PRIMZONEFULLFEED9869345) on November 03, 2026, and is solely responsible for the information contained therein.